In this upbeat interview, CEO Jerry Randall of @venturelifegp takes me through today’s 'in line' interim results and positive FY'23 outlook - with H1’23 EBITDA climbing 33% to £4.4m on LFL sales 10.4% higher (Est split 8% volume vs 2% price) to £23.5m.
Disclosure: Vox markets paid me to interview Venture Life
Stocks owned : EQLS, AGFX, Pfizer, Bristol Myers, Roche, WATR, VCT, MBH, ASTO, IOM, TR25, ESYS, ELCO, IHC, Paypal & AOM Elsewhere, I'm also paid by Vox Markets (as a contractor) to interview interview fund managers, capital market experts & companies (re EQLS, VRCI, BELL, FIN, AVG, AVCT, LLAI, VLG, FADL, SUP, ELCO, LORD , MPAC & ONC). I believe all these stocks are clients of Vox.Lastly my 24 year HIT RATE is only 62%. Meaning 38% of the time I lose money (ie often wrong) - albeit my winners are (on average) 1.5x larger than my losers. Please Do Your Own Research. more »
Venture Life have signed up for Mello London so will be available on their stand and doing two presentations on Thursday 30th November in Chiswick https://melloevents.com/mltick... Lots of interesting companies and speakers. Paul Hill will be doing the breakfast show
Cavendish (ex finncap & Cenkos) have a 68p/share target price for Venture Life (LON:VLG), who they reckon will generate a >16% FCF yield in 2023 & 2024
